Ask The Recruiter

Tempest Therapeutics, Inc.

Leadership moves, last update 3 months ago

Pharma biotech · Headquarters United States

Everything we hold on Tempest Therapeutics, Inc., newest first. Every line links to the filing or report it came from.

3 updates tracked
$2M disclosed funding
2 leadership changes
28 Jan 2026 tracked since
United States where
  1. 2026-06-04
    Headcount Not Stated Leadership moves

    Tempest Therapeutics Announces Leadership Transition

    Tempest Therapeutics transitions its CFO role in Brisbane, with Justin Trojanowski stepping into the position effective June 5, 2026.

    United States · Official Filing · SEC EDGAR

  2. 2026-04-03
    Headcount Not Stated Growing and expanding

    Tempest Therapeutics, Inc. raised $2M in a private placement

    Tempest Therapeutics, Inc. reported a $2M private placement to the SEC on 2026-04-03, listing an address in CA. The filing records the money only; it names no roles and no hiring plan.

    United States · $2M raised · Official Filing · SEC EDGAR (Form D)

  3. 2026-01-28
    Headcount Not Stated Leadership moves

    Tempest Therapeutics, Inc. 8-K filing (Item 5.02): officer or director change

    A leadership change at Tempest Therapeutics in Brisbane affects executive roles.

    United States · Official Filing · SEC EDGAR

Cite this pageTempest Therapeutics, Inc.. Talent Intelligence Tracker, AskTheRecruiter.com. Accessed Aug 20, 2026. https://asktherecruiter.com/blog/talent-intelligence-tracker/company/tempest-therapeutics/ Licensed CC BY 4.0; every record links to the document behind it.

The read-through on each line is our interpretation. The headline and figures come from the linked source. Data licensed CC BY 4.0. Back to the tracker